Sequent Scientific Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 68.51 | 49.75 | 55.65 |
| Operating Expense | 59.65 | 42.53 | 46.36 |
| Net Profit | 4.50 | 3.76 | 4.58 |
| Net Profit Margin | 6.57 | 7.56 | 8.23 |
| Earning Per Share | 0.18 | 0.15 | 0.18 |
| EBIDTA | 8.28 | 6.88 | 8.24 |
| Effective Tax Rate | 10.95 | TBA | 4.95 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 68.51 |
| Operating Expense | 59.65 |
| Net Profit | 4.50 |
| Net Profit Margin | 6.57 |
| Earning Per Share | 0.18 |
| EBIDTA | 8.28 |
| Effective Tax Rate | 10.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 168.52 | 222.69 | 219.63 |
| Operating Expenses Annual | 195.18 | 249.05 | 220.38 |
| Operating Profit Annual | 13.06 | 1.88 | 26.89 |
| Interest Annual | 4.36 | 2.51 | 1.61 |
| Depreciation | 8.76 | 8.64 | 8.47 |
| Net Profit Annual | 0.62 | -6.08 | 14.80 |
| Tax Annual | -0.86 | -3.67 | 0.89 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 168.52 |
| Operating Expenses Annual | 195.18 |
| Operating Profit Annual | 13.06 |
| Interest Annual | 4.36 |
| Depreciation | 8.76 |
| Net Profit Annual | 0.62 |
| Tax Annual | -0.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.08 | 12.80 | 0.44 |
| Cash Flow from Operations | -26.94 | 37.75 | 9.36 |
| Cash Flow from Investing | 5.47 | -50.70 | -4.25 |
| Cash Flow from Financing | 22.32 | 0.24 | 7.25 |
| Cash Flow at the End | 0.93 | 0.08 | 12.80 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.08 |
| Cash Flow from Operations | -26.94 |
| Cash Flow from Investing | 5.47 |
| Cash Flow from Financing | 22.32 |
| Cash Flow at the End | 0.93 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 8.75 | 0.84 | 12.24 |
| PBIT Margin (%) | 3.45 | -3.25 | 7.88 |
| PBT Margin (%) | 2.66 | -1.96 | 2.99 |
| Net PROFIT Margin (%) | 0.37 | -2.73 | 6.74 |
| Return On Networth / Equity (%) | 0.22 | -0.58 | 1.43 |
| Return On Networth /Employed (%) | 0.52 | -0.68 | 1.65 |
| Return On Assets (%) | 0.06 | -0.57 | 1.42 |
| Total Debt / Equity (X) | 0.03 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 0.15 | 0.21 | 0.21 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 8.75 |
| PBIT Margin (%) | 3.45 |
| PBT Margin (%) | 2.66 |
| Net PROFIT Margin (%) | 0.37 |
| Return On Networth / Equity (%) | 0.22 |
| Return On Networth /Employed (%) | 0.52 |
| Return On Assets (%) | 0.06 |
| Total Debt / Equity (X) | 0.03 |
| Asset Turnover Ratio (%) | 0.15 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 42.52 | 56.72 | 66.90 |
| Total Current Assets Annual | 96.78 | 75.02 | 145.86 |
| Non Current Assets Annual | 1,082.42 | 1,037.66 | 978.37 |
| Total Shareholders Funds Annual | 1,087.23 | 1,058.36 | 1,041.09 |
| Total Assets Annual | 1,187.60 | 1,122.77 | 1,124.23 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 42.52 |
| Total Current Assets Annual | 96.78 |
| Non Current Assets Annual | 1,082.42 |
| Total Shareholders Funds Annual | 1,087.23 |
| Total Assets Annual | 1,187.60 |
EPS (INR)
Expected
0.26
Reported
0.26
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.00%
